Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Strata Skin Sciences, Inc. (MELA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Strata Skin Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1051514.
Total stock buying since 2014: $3,030,311.
Total stock sales since 2014: $327,110.
Total stock option exercises since 2014: $19,350.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 480,246 | $1,507,972 | 0 | $0 | 0 | $0 |
| 2023 | 1,930,207 | $1,070,490 | 1,000 | $320 | 0 | $0 |
| 2022 | 89,214 | $132,189 | 0 | $0 | 0 | $0 |
| 2021 | 71,420 | $103,575 | 0 | $0 | 0 | $0 |
| 2020 | 0 | $0 | 0 | $0 | 15,000 | $19,350 |
| 2019 | 5,000 | $12,500 | 0 | $0 | 0 | $0 |
| 2018 | 73,000 | $147,770 | 0 | $0 | 0 | $0 |
| 2016 | 20,000 | $10,100 | 266,000 | $326,790 | 0 | $0 |
| 2014 | 97,500 | $45,715 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-07 | 480,246 | $1,507,972 | 0 | $0 | 0 | $0 |
| 2023-12 | 20,000 | $9,100 | 0 | $0 | 0 | $0 |
| 2023-11 | 0 | $0 | 1,000 | $320 | 0 | $0 |
| 2023-08 | 1,910,207 | $1,061,390 | 0 | $0 | 0 | $0 |
| 2022-06 | 1,050 | $1,092 | 0 | $0 | 0 | $0 |
| 2022-05 | 23,131 | $25,906 | 0 | $0 | 0 | $0 |
| 2022-03 | 65,033 | $105,191 | 0 | $0 | 0 | $0 |
| 2021-09 | 71,420 | $103,575 | 0 | $0 | 0 | $0 |
| 2020-10 | 0 | $0 | 0 | $0 | 15,000 | $19,350 |
| 2019-11 | 5,000 | $12,500 | 0 | $0 | 0 | $0 |
| 2018-06 | 70,000 | $142,730 | 0 | $0 | 0 | $0 |
| 2018-05 | 3,000 | $5,040 | 0 | $0 | 0 | $0 |
| 2016-11 | 20,000 | $10,100 | 0 | $0 | 0 | $0 |
| 2016-03 | 0 | $0 | 266,000 | $326,790 | 0 | $0 |
| 2014-12 | 10,000 | $12,290 | 0 | $0 | 0 | $0 |
| 2014-05 | 87,500 | $33,425 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-15 | Accelmed Growth Partners Management Ltd. | Buy | 230,573 | 3.14 | 723,999 |
| 2024-07-15 | Rafaeli Dolev (Chief Executive Officer) | Buy | 19,100 | 3.14 | 59,974 |
| 2024-07-15 | Geiger Uri | Buy | 230,573 | 3.14 | 723,999 |
| 2023-12-01 | Gov Shmuel (COO) | Buy | 20,000 | .46 | 9,100 |
| 2023-11-16 | Rubinstein Samuel | Sale | 1,000 | .32 | 320 |
| 2023-08-16 | English Aron R. | Buy | 1,853,056 | .55 | 1,022,886 |
| 2023-08-10 | Lesovitz Christopher (Chief Financial Officer) | Buy | 15,151 | .67 | 10,196 |
| 2023-08-10 | Moccia Robert Joseph (Chief Executive Officer) | Buy | 42,000 | .67 | 28,308 |
| 2022-06-15 | Rubinstein Samuel | Buy | 1,050 | 1.04 | 1,092 |
| 2022-05-12 | Lesovitz Christopher (Chief Financial Officer) | Buy | 23,131 | 1.12 | 25,906 |
| 2022-03-25 | Humphries William D. | Buy | 16,950 | 1.73 | 29,391 |
| 2022-03-24 | Moccia Robert Joseph (Chief Executive Officer) | Buy | 33,300 | 1.57 | 52,414 |
| 2022-03-24 | Humphries William D. | Buy | 14,783 | 1.58 | 23,386 |
| 2021-09-08 | Shamir Nachum | Buy | 44,808 | 1.47 | 65,733 |
| 2021-09-07 | Shamir Nachum | Buy | 26,612 | 1.42 | 37,842 |
| 2020-10-09 | Navarro Samuel E | Option Ex | 15,000 | 1.29 | 19,350 |
| 2019-11-21 | Via Luann | Buy | 5,000 | 2.50 | 12,500 |
| 2018-06-14 | Via Luann | Buy | 5,000 | 1.95 | 9,750 |
| 2018-06-14 | Hill Matthew C (CFO) | Buy | 10,000 | 1.96 | 19,600 |
| 2018-06-08 | Via Luann | Buy | 30,000 | 2.07 | 63,500 |
| 2018-06-05 | Navarro Samuel E | Buy | 20,000 | 1.99 | 39,880 |
| 2018-05-21 | Coyne James L | Buy | 3,000 | 1.68 | 5,040 |
| 2016-11-28 | Mccaney Frank J (President & CEO) | Buy | 20,000 | .51 | 10,100 |
| 2016-03-11 | Kotler Kevin | Sale | 216,000 | 1.17 | 251,640 |
| 2016-03-10 | Kotler Kevin | Sale | 50,000 | 1.50 | 75,150 |
| 2014-12-31 | Cook Robert W. (Chief Financial Officer) | Buy | 10,000 | 1.23 | 12,290 |
| 2014-05-22 | Dimun Anthony J (Director) | Buy | 87,500 | .38 | 33,425 |
Insider trading activities including stock purchases, stock sales, and option exercises of MELA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Strata Skin Sciences, Inc. (symbol MELA, CIK number 1051514) see the Securities and Exchange Commission (SEC) website.